We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
-10.3%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.85B
AUM Growth
-$949M
(-20%)
Cap. Flow
-$393M
Cap. Flow
% of AUM
-10.22%
Top 10 Holdings %
Top 10 Hldgs %
10.07%
Holding
2,323
New
652
Increased
471
Reduced
539
Closed
577
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATHN
Athenahealth, Inc.
ATHN
|
+$67.9M |
| 2 |
FSAC
Federal Street Acquisition Corp. Common Stock
FSAC
|
+$45.5M |
| 3 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$45.2M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$34.6M |
| 5 |
NFX
Newfield Exploration
NFX
|
+$33.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$105M |
| 2 |
COL
Rockwell Collins
COL
|
+$84.8M |
| 3 |
CA
CA, Inc.
CA
|
+$72.4M |
| 4 |
ANDV
Andeavor
ANDV
|
+$52.9M |
| 5 |
PF
Pinnacle Foods, Inc.
PF
|
+$41.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.44% |
| 2 | Consumer Discretionary | 14.53% |
| 3 | Healthcare | 13.43% |
| 4 | Industrials | 13.16% |
| 5 | Financials | 12.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVP
451
DELISTED
Avon Products, Inc.
AVP
| $2.07M | 0.05% |
1,359,895
-195,534
| -13% | -$375K |
|
452
MacroGenics
MGNX
$257M
| $2.05M | 0.05% |
161,486
+71,906
| +80% | +$1.21M |
|
453
Kulicke & Soffa
KLIC
$4.78B
| $2.05M | 0.05% |
101,066
-1,918
| -2% | -$39.7K |
|
454
MillerKnoll
MLKN
$1.67B
| $2.05M | 0.05% |
67,641
-65,870
| -49% | -$2.19M |
|
|
BSTC
455
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $2.04M | 0.05% |
33,707
-1,120
| -3% | -$66.9K |
|
456
MDU Resources
MDU
$4.32B
| $2.04M | 0.05% |
225,229
+38,044
| +20% | +$371K |
|
|
FRGI
457
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $2.04M | 0.05% |
131,236
+41,357
| +46% | +$901K |
|
|
EEX
458
DELISTED
Emerald Holding
EEX
| $2.03M | 0.05% |
164,657
+35,687
| +28% | +$462K |
|
|
NUVA
459
DELISTED
NuVasive, Inc.
NUVA
| $2.03M | 0.05% |
40,984
+28,394
| +226% | +$1.71M |
|
460
Monro
MNRO
$398M
| $2.03M | 0.05% |
+29,523
| New | +$2.16M |
|
461
Noodles & Co
NDLS
$107M
| $2.02M | 0.05% |
+36,157
| New | +$2.69M |
|
462
Harmonic Inc
HLIT
$1.28B
| $2.02M | 0.05% |
427,862
+206,358
| +93% | +$1.13M |
|
463
CRA International
CRAI
$1.06B
| $2.01M | 0.05% |
47,245
-12,281
| -21% | -$552K |
|
|
LORL
464
DELISTED
Loral Space and Communications, Inc.
LORL
| $1.99M | 0.05% |
53,481
-18,295
| -25% | -$786K |
|
465
Haverty Furniture Companies
HVT
$454M
| $1.99M | 0.05% |
105,782
+4,029
| +4% | +$82.8K |
|
|
IMGN
466
DELISTED
Immunogen Inc
IMGN
| $1.99M | 0.05% |
+413,953
| New | +$2.51M |
|
|
PTR
467
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $1.99M | 0.05% |
32,277
-12,494
| -28% | -$895K |
|
|
EVRI
468
DELISTED
Everi Holdings
EVRI
| $1.98M | 0.05% |
384,823
+158,557
| +70% | +$1.08M |
|
|
RARX
469
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $1.98M | 0.05% |
108,592
+17,418
| +19% | +$273K |
|
470
US Physical Therapy
USPH
$1.22B
| $1.97M | 0.05% |
19,286
-926
| -5% | -$103K |
|
471
Diodes
DIOD
$4.84B
| $1.97M | 0.05% |
61,159
-42,652
| -41% | -$1.36M |
|
472
Guardant Health
GH
$22.6B
| $1.97M | 0.05% |
+52,473
| New | +$1.93M |
|
473
Walker & Dunlop
WD
$1.53B
| $1.97M | 0.05% |
45,532
+10,725
| +31% | +$493K |
|
|
VSM
474
DELISTED
Versum Materials, Inc.
VSM
| $1.97M | 0.05% |
71,036
-37,077
| -34% | -$1.17M |
|
|
BFX
475
DELISTED
BowFlex Inc.
BFX
| $1.96M | 0.05% |
180,136
+31,770
| +21% | +$397K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Oxford Asset Management held 2,323 positions worth $3.85B, down 20% from $4.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Oxford Asset Management withdrew a net $393M in Q4 2018, closing 577 positions and reducing 539 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $105M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Oxford Asset Management opened a new position in Athenahealth, Inc. worth $69.9M.
- Oxford Asset Management's largest Q4 2018 buy was Athenahealth, Inc.: 530,000 shares worth $69.9M.
- Oxford Asset Management added most to Integrated Device Technology I in Q4 2018, an estimated $34.6M increase.
- Oxford Asset Management's biggest Q4 2018 reduction was GE Aerospace, cutting an estimated $18.1M.
- Oxford Asset Management fully exited Envision Healthcare Holdings Inc in Q4 2018, selling an estimated $105M.
- Oxford Asset Management's ten largest holdings make up 10% of its $3.85B portfolio in Q4 2018.
- Oxford Asset Management opened 652 new positions and closed 577 in Q4 2018.
- Oxford Asset Management's portfolio value fell 20% quarter-over-quarter to $3.85B.
Based on Oxford Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.